Back to Ovarian Cancer
NCT01081639
NCT01081639
Who may be able to join
Who might be able to join this trial:
- You are a woman who has not yet gone through menopause and are between 18 and 39 years old
- You are receiving a man-made hormone called FSH as part of IVF or ICSI fertility treatment
- You are able to communicate clearly with the research team and are willing to follow all study requirements
- You have read and signed a consent form agreeing to take part, and understand you can withdraw at any time without any negative consequences
Who may not be able to join:
- You have had a known allergic reaction to any of the ingredients in the study treatment
- You have enlarged ovaries or ovarian cysts that are not related to polycystic ovary syndrome (PCOS)
- You have unexplained gynaecological (reproductive system) bleeding
- You have been diagnosed with cancer of the ovaries, uterus (womb), or breast
- You have a tumour affecting the hypothalamus or pituitary gland, which are hormone-controlling areas of the brain (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 3
Sponsor
Merck KGaA, Darmstadt, Germany
Registry
clinicaltrials_gov
Start date
1 November 2003
Est. completion
1 September 2004
Primary endpoints
Convenience and Safety
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.